UBS more constructive on CME Group following underperformance UBS is more constructive on CME Group following recent underperformance and said January volumes are off to a good start and activity should improve. The firm reiterates its Buy rating and $83 price target.
News For CME From The Last 14 Days
Check below for free stories on CME the last two weeks.
On The Fly: Analyst Upgrade Summary Abercrombie & Fitch (ANF) upgraded to Outperform from Neutral at Credit Suisse... GrafTech (GTI) upgraded to Buy from Hold at Jefferies... Hilton (HLT) upgraded to Buy from Neutral at Goldman... Magna (MGA) upgraded to Neutral from Sell at Goldman... PulteGroup (PHM) upgraded to Buy from Hold at KeyBanc... SunEdison (SUNE) upgraded to Overweight from Equal Weight at Morgan Stanley... WNS Holdings (WNS) upgraded to Outperform from Neutral at RW Baird... CME Group (CME) upgraded to Buy from Hold at Argus.
CME Group reports contracts volume in February up 2% YoY CME Group announced that February 2014 volume averaged 14.0 million contracts per day, up 2% compared with February 2013 – and up 8% from January 2014. Total volume for February 2014 was more than 266M contracts, of which 86% was traded electronically. Year-to-date 2014 average daily volume of 13.4M contracts was up 7% compared with the same time period last year.